Parkinson Disease: A Health Policy Perspective

Part of the successful Institute of Health Economics (IHE) book series, this handbook and ready reference adopts a unique approach in combining policy recommendations with specific treatment options for Parkinson patients.
The first part of the book deals with the clinical medical, social and economical aspects of Parkinson Disease. These ten chapters include the latest diagnosis and treatment options for patients, the economical consequences, social and ethical implications and end–of life issues. The second part of the book essentially covers a large–scale case study on Parkinson in Alberta, Canada, since most of the issues discussed are relevant in all developed countries.
With its strong focus on correct diagnosis and early intervention, this is an invaluable guide for clinicians and policymakers dealing with this devastating disease.


Spis treści:
PARKINSON DISEASE –
DIAGNOSIS AND TREATMENT
Summary and Policy Considerations (Martin, Suchowersky, Kovacs Burns, Jonsson)
Parkinson Disease (Williams)
Clinical Features of Parkinson Disease (Martin)
Current Approach to the Management of Parkinson Disease (Martin, Wieler)
Treatment of Non–Motor Symptoms of Parkinson Disease (Ranawaya, Suchowersky)
Palliative Care and End of life issues with Parkinson Disease (Derwent, Hunka, Suchowersky)
Natural Health Products in Parkinson Disease (Sadowski, Heschuk)
Can the Art of Medicine use Arts as Medicine? A Personal Perspective (Pinckney)
The Costs of Parkinson Disease (Ohinmaa)
A Literature Summary on Parkinson Disease (Corabian, Dennett)
Highlights of Current Research in Parkinson Disease (Martin, Hu)
THE CASE OF ALBERTA, CANADA
The Incidence and Prevalence of Parkinson Disease in Alberta (Svenson, Yiannakoulias)
Knowledge, Service Access, and Needs of Individuals Living with Parkinson Disease: The Alberta Case (Kovacs Burns)
Caregivers of Persons with Parkinson Disease: E xperiences and Perspectives (Kovacs Burns)
Health–related Quality of Life in Parkinson Disease: An introduction to concepts and methods
(Wieler, Jones)
Measuring Health–related Quality of Life in PD: How Does It Compare to the Canadian General Population? (Jones, Pohar)
Policy Considerations for Alberta
Parkinson Disease FAQ Sheet
Glossary of Terms


Nota biograficzna:
Wayne Martin, MD, FRCPC, Movement Disorders Clinic, University of Alberta/Glenrose Rehabilitation Hospital, Edmonton, Alberta
Dr. Martin received his undergraduate and medical education from the University of Alberta. After completing a neurology residency at the University of British Columbia in Vancouver, he obtained postgraduate research training at Washington University in St. Louis. He then returned to Vancouver to join the University of British Columbia neurology faculty as part of the movement disorders group. In 1990, he returned to the University of Alberta as a Professor in the Division of Neurology and Director of the Movement Disorders Clinic. He remains active in research with particular interests in neuroimaging and in clinical trials of new treatments in movement disorders.
Oksana Suchowersky, MD FRCPC, Movement Disorders Program, Hotchkiss Brain Institute, Calgary Alberta
Katharina Kovacs Burns, MSc, MHSA, PhD, Health Sciences Council, University of Alberta, Edmonton, Alberta Email: kathykovacsburns@shaw.ca
Egon Jonsson, PhD, Professor, University of Alberta, School of Public Health, Edmonton, Alberta; University of Calgary, Community Health Sciences, Calgary, Alberta; Executive Director & CEO, Institute of Health Economics, Edmonton, Alberta